{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:55:12Z","timestamp":1781636112385,"version":"3.54.5"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sleep disturbances are among the most disabling non-motor symptoms in Parkinson\u2019s disease (PD), particularly affecting older adults, in whom age-related vulnerability and multimorbidity may exacerbate sleep dysfunction. Despite their high prevalence, interventional evidence reporting sleep-related outcomes in PD remains incompletely characterized, and methodological heterogeneity limits the comparability of findings across studies. This registry-based descriptive review aimed to characterize the landscape of late-stage interventional trials reporting sleep-related outcomes in PD, with attention to study design, older-adult eligibility, and intervention types.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A descriptive analysis of completed late-stage interventional studies registered on ClinicalTrials.gov was conducted. Late-stage was operationally defined as Phase III\u2013IV interventional trials and explicitly linked open-label extension\/rollover studies. Eligible studies permitted enrolment of adults aged\u2009\u2265\u200965\u00a0years with Parkinson\u2019s disease and reported at least one sleep-related outcome. Extracted data included intervention type, study design, sleep outcome measures, and study duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-one trials met inclusion criteria. Most focused on dopaminergic or adjunctive pharmacologic interventions, including rotigotine, pramipexole, and levodopa\u2013carbidopa intestinal gel. Reported sleep-related outcomes were primarily derived from subjective instruments such as the Parkinson\u2019s Disease Sleep Scale (PDSS\/PDSS-2) or SCOPA-Sleep, while objective assessments such as polysomnography or actigraphy were infrequently specified. No completed late-stage trials evaluating structured behavioral or circadian-oriented interventions, including cognitive-behavioral therapy for insomnia, exercise, or bright-light therapy, were identified. Eligibility criteria suggested that clinically vulnerable populations, including frail or cognitively impaired individuals, were likely underrepresented.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Late- stage interventional evidence reporting sleep-related outcomes in PD remains predominantly pharmacologic, short-term, and methodologically heterogeneous. The absence of completed behavioral or multimodal trials and eligibility criteria that may limit inclusion of clinically vulnerable individuals highlight important evidence gaps. Future research should prioritize inclusive, geriatric-informed, and multimodal designs incorporating both subjective and objective sleep measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-026-07089-3","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T01:52:59Z","timestamp":1771293179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Late-stage interventional trials reporting sleep-related outcomes in older adults with Parkinson\u2019s disease: a ClinicalTrials.gov registry review"],"prefix":"10.1186","volume":"26","author":[{"given":"Fahad J.","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Aldurdunji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"16","key":"7089_CR1","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1002\/mds.23190","volume":"25","author":"B H\u00f6gl","year":"2010","unstructured":"H\u00f6gl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, et al Scales to assess sleep impairment in Parkinson\u2019s disease: Critique and recommendations. Mov Disord. 2010;25(16):2704\u201316. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.23190.","journal-title":"Mov Disord"},{"issue":"5","key":"7089_CR2","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1212\/01.wnl.0000233980.25978.9d","volume":"67","author":"MD Gjerstad","year":"2006","unstructured":"Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP Excessive daytime sleepiness in Parkinson disease. Neurology. 2006;67(5):853\u20138. Available from:. https:\/\/www.neurology.org\/doi\/10.1212\/01.wnl.0000233980.25978.9d.","journal-title":"Neurology"},{"issue":"11","key":"7089_CR3","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Molloy S, Bain G, Chaudhuri P, Piccini KR Parkinson\u2019s disease symptoms: The patient\u2019s perspective. Mov Disord. 2010;25(11):1646\u201351. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.23135.","journal-title":"Mov Disord"},{"issue":"9","key":"7089_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/aje\/kwq478","volume":"173","author":"J Gao","year":"2011","unstructured":"Gao J, Huang X, Park Y, Hollenbeck A, Blair A, Schatzkin A, et al Daytime Napping, Nighttime Sleeping, and Parkinson Disease. Am J Epidemiol. 2011;173(9):1032\u20138. Available from:. https:\/\/academic.oup.com\/aje\/article-lookup\/doi\/10.1093\/aje\/kwq478.","journal-title":"Am J Epidemiol"},{"key":"7089_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.nicl.2017.05.012","volume":"15","author":"LJ de Schipper","year":"2017","unstructured":"de Schipper LJ, van der Grond J, Marinus J, Henselmans JML, van Hilten JJ Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson\u2019s disease. NeuroImage Clin. 2017;15:587\u201393. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158217301171.","journal-title":"NeuroImage Clin"},{"issue":"11","key":"7089_CR6","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s10072-015-2288-9","volume":"36","author":"A Ylikoski","year":"2015","unstructured":"Ylikoski A, Martikainen K, Sieminski M, Partinen M Parkinson\u2019s disease and insomnia. Neurol Sci. 2015;36(11):2003\u201310. Available from:. http:\/\/link.springer.com\/10.1007\/s10072-015-2288-9.","journal-title":"Neurol Sci"},{"issue":"2","key":"7089_CR7","first-page":"147","volume":"4","author":"G Ilkhan","year":"2021","unstructured":"Ilkhan G, Celi\u0307khi\u0307sar H, Kilavuz A The evaluation of sleep quality, anxiety disorder and depression in older adults with Parkinson disease. J Heal Sci Med. 2021;4(2):147\u201353. Available from: http:\/\/dergipark.org.tr\/en\/doi\/10.32322\/jhsm.848699.","journal-title":"J Heal Sci Med"},{"issue":"1","key":"7089_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/mdc3.14254","volume":"12","author":"E Antelmi","year":"2025","unstructured":"Antelmi E, Lanza G, Mogavero MP, Mingolla GP, Plazzi G, Ferini\u2010Strambi L, et al Intersection of Sleep Disorders and Parkinson Disease: Unveiling the Bidirectional Relationship. Mov Disord Clin Pract. 2025;12(1):11\u201320. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mdc3.14254.","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"7089_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.5664\/jcsm.3150","volume":"09","author":"S Chung","year":"2013","unstructured":"Chung S, Bohnen NI, Albin RL, Frey KA, M\u00fcller MLTM, Chervin RD Insomnia and Sleepiness in Parkinson Disease: Associations with Symptoms and Comorbidities. J Clin Sleep Med. 2013;09(11):1131\u20137. Available from:. http:\/\/jcsm.aasm.org\/doi\/10.5664\/jcsm.3150.","journal-title":"J Clin Sleep Med"},{"key":"7089_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.parkreldis.2017.01.015","volume":"39","author":"S van der Rutten","year":"2017","unstructured":"Rutten S, Vriend C, van der Werf YD, Berendse HW, Weintraub D, van den Heuvel OA The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-na\u00efve Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;39:31\u20136. Available from:. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802017300342.","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"7089_CR11","first-page":"585","volume":"31","author":"RKM Fadol","year":"2023","unstructured":"Fadol RKM, Daoud MHS, Saeed MK, Mohmed MHA, Ali KM, Elsayed MAM. Sleep Disorders in Patients with Parkinson Disease and its Correlation to Motor Symptoms Severity. J Alzheimers Dis Park. 2023;31(13):585.","journal-title":"J Alzheimers Dis Park"},{"key":"7089_CR12","doi-asserted-by":"crossref","unstructured":"Postuma RB, Gagnon J, Pelletier A, Montplaisir JY. Insomnia and somnolence in idiopathic RBD: a prospective cohort study. npj Park Dis. 2017;3(1):9. Available from: https:\/\/www.nature.com\/articles\/s41531-017-0011-7.","DOI":"10.1038\/s41531-017-0011-7"},{"key":"7089_CR13","doi-asserted-by":"crossref","unstructured":"Wallace DM, Wohlgemuth WK, Trotti LM, Amara AW, Malaty IA, Factor SA, et al. Practical Evaluation and Management of Insomnia in Parkinson\u2019s Disease: A Review. Mov Disord Clin Pract. 2020;7(3):250\u201366. Available from: https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mdc3.12899.","DOI":"10.1002\/mdc3.12899"},{"key":"7089_CR14","doi-asserted-by":"crossref","unstructured":"Maass A, Reichmann H. Sleep and non-motor symptoms in Parkinson\u2019s disease. J Neural Transm. 2013;120(4):565\u20139. Available from: http:\/\/link.springer.com\/10.1007\/s00702-013-0966-4.","DOI":"10.1007\/s00702-013-0966-4"},{"issue":"8","key":"7089_CR15","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00415-006-0483-6","volume":"254","author":"S Happe","year":"2007","unstructured":"Happe S, Baier PC, Helmschmied K, Meller J, Tatsch K, Paulus W Association of daytime sleepiness with nigrostriatal dopaminergic degeneration in early Parkinson\u2019s disease. J Neurol. 2007;254(8):1037\u201343. Available from:. http:\/\/link.springer.com\/10.1007\/s00415-006-0483-6.","journal-title":"J Neurol"},{"key":"7089_CR16","doi-asserted-by":"crossref","unstructured":"Loddo G, Calandra-Buonaura G, Sambati L, Giannini G, Cecere A, Cortelli P, et al. The Treatment of Sleep Disorders in Parkinson\u2019s Disease: From Research to Clinical Practice. Front Neurol. 2017;8. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2017.00042\/full.","DOI":"10.3389\/fneur.2017.00042"},{"issue":"10","key":"7089_CR17","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s00415-012-6505-7","volume":"259","author":"M Louter","year":"2012","unstructured":"Louter M, Aarden WCCA, Lion J, Bloem BR, Overeem S Recognition and diagnosis of sleep disorders in Parkinson\u2019s disease. J Neurol. 2012;259(10):2031\u201340. Available from:. http:\/\/link.springer.com\/10.1007\/s00415-012-6505-7.","journal-title":"J Neurol"},{"issue":"1","key":"7089_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12883-022-02830-y","volume":"22","author":"T Li","year":"2022","unstructured":"Li T, Zou S, Zhang Z, Liu M, Liang Z Efficacy of pramipexole on quality of life in patients with Parkinson\u2019s disease: a systematic review and meta-analysis. BMC Neurol. 2022;22(1):320. Available from:. https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02830-y.","journal-title":"BMC Neurol"},{"issue":"2","key":"7089_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1212\/WNL.0000000000001737","volume":"85","author":"LK Tholfsen","year":"2015","unstructured":"Tholfsen LK, Larsen JP, Schulz J, Tysnes OB, Gjerstad MD Development of excessive daytime sleepiness in early Parkinson disease. Neurology. 2015;85(2):162\u20138. Available from:. https:\/\/www.neurology.org\/doi\/10.1212\/WNL.0000000000001737.","journal-title":"Neurology"},{"issue":"3","key":"7089_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2165\/11539720-000000000-00000","volume":"25","author":"B Knie","year":"2011","unstructured":"Knie B, Mitra MT, Logishetty K, Chaudhuri KR Excessive Daytime Sleepiness in Patients with Parkinson\u02bcs Disease. CNS Drugs. 2011;25(3):203\u201312. Available from:. http:\/\/link.springer.com\/10.2165\/11539720-000000000-00000.","journal-title":"CNS Drugs"},{"issue":"6","key":"7089_CR21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mds.28009","volume":"35","author":"AW Amara","year":"2020","unstructured":"Amara AW, Wood KH, Joop A, Memon RA, Pilkington J, Tuggle SC, et al Randomized, Controlled Trial of Exercise on Objective and Subjective Sleep in Parkinson\u2019s Disease. Mov Disord. 2020;35(6):947\u201358. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.28009.","journal-title":"Mov Disord"},{"issue":"2","key":"7089_CR22","doi-asserted-by":"publisher","first-page":"e2037199","DOI":"10.1001\/jamanetworkopen.2020.37199","volume":"4","author":"PM Siu","year":"2021","unstructured":"Siu PM, Yu AP, Tam BT, Chin EC, Yu DS, Chung K, et al Effects of Tai Chi or Exercise on Sleep in Older Adults With Insomnia. JAMA Netw Open. 2021;4(2):e2037199. Available from:. https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776441.","journal-title":"JAMA Netw Open"},{"key":"7089_CR23","doi-asserted-by":"crossref","unstructured":"Videnovic A, Klerman EB, Wang W, Marconi A, Kuhta T, Zee PC. Timed Light Therapy for Sleep and Daytime Sleepiness Associated With Parkinson Disease. JAMA Neurol. 2017;74(4):411. Available from: http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2016.5192.","DOI":"10.1001\/jamaneurol.2016.5192"},{"issue":"14","key":"7089_CR24","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/mds.25197","volume":"27","author":"T Peeraully","year":"2012","unstructured":"Peeraully T, Yong M, Chokroverty S, Tan E Sleep and Parkinson\u2019s disease: A review of case\u2010control polysomnography studies. Mov Disord. 2012;27(14):1729\u201337. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.25197.","journal-title":"Mov Disord"},{"key":"7089_CR25","doi-asserted-by":"crossref","unstructured":"Ma R, Yin Z, Chen Y, Yuan T, An Q, Gan Y, et al. Sleep outcomes and related factors in Parkinson\u2019s disease after subthalamic deep brain electrode implantation: a retrospective cohort study. Ther Adv Neurol Disord. 2023;16. Available from: https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864231161163.","DOI":"10.1177\/17562864231161163"},{"issue":"5","key":"7089_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/geriatrics7050089","volume":"7","author":"P Limpawattana","year":"2022","unstructured":"Limpawattana P, Khammak C, Manjavong M, So-ngern A Frailty as a Predictor of Hospitalization and Low Quality of Life in Geriatric Patients at an Internal Medicine Outpatient Clinic: A Cross-Sectional Study. Geriatrics. 2022;7(5):89. Available from:. https:\/\/www.mdpi.com\/2308-3417\/7\/5\/89.","journal-title":"Geriatrics"},{"key":"7089_CR27","doi-asserted-by":"crossref","unstructured":"Corral-P\u00e9rez J, Casals C, \u00c1vila-Cabeza-de-Vaca L, Gonz\u00e1lez-Mariscal A, Mart\u00ednez-Zaragoza I, Villa-Estrada F, et al. Health factors associated with cognitive frailty in older adults living in the community. Front Aging Neurosci. 2023;15. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2023.1232460\/full.","DOI":"10.3389\/fnagi.2023.1232460"},{"issue":"2","key":"7089_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11910-996-0041-8","volume":"6","author":"DB Rye","year":"2006","unstructured":"Rye DB Excessive daytime sleepiness and unintended sleep in Parkinson\u2019s disease. Curr Neurol Neurosci Rep. 2006;6(2):169\u201376. Available from:. http:\/\/link.springer.com\/10.1007\/s11910-996-0041-8.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"7089_CR29","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/brain\/awv215","volume":"138","author":"Z Qamhawi","year":"2015","unstructured":"Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, et al Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease. Brain. 2015;138(10):2964\u201373. Available from:. https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awv215.","journal-title":"Brain"},{"issue":"6","key":"7089_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jnnp.73.6.629","volume":"73","author":"KR Chaudhuri","year":"2002","unstructured":"Chaudhuri KR, Pal S, DiMarco A, Whately-Smith C, Bridgman K, Mathew R, et al The Parkinson\u2019s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2002;73(6):629\u201335. Available from:. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12438461.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"7089_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/mds.23476","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder C, Kohnen R, H\u00f6gl B, Metta V, Sixel-D\u00f6ring F, Frauscher B, et al Parkinson\u2019s disease sleep scale--validation of the revised version PDSS-2. Mov Disord. 2011;26(4):644\u201352. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.23476.","journal-title":"Mov Disord"},{"issue":"8","key":"7089_CR32","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/sleep\/26.8.1049","volume":"26","author":"J van Marinus","year":"2003","unstructured":"Marinus J, Visser M, van Hilten JJ, Lammers GJ, Stiggelbout AM Assessment of Sleep and Sleepiness in Parkinson Disease. Sleep. 2003;26(8):1049\u201354. Available from:. https:\/\/academic.oup.com\/sleep\/article-lookup\/doi\/10.1093\/sleep\/26.8.1049.","journal-title":"Sleep"},{"key":"7089_CR33","doi-asserted-by":"crossref","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193\u2013213. Available from. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2748771","DOI":"10.1016\/0165-1781(89)90047-4"},{"issue":"6","key":"7089_CR34","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540\u20135. Available from:. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1798888","journal-title":"Sleep"},{"issue":"5","key":"7089_CR35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin CM, Belleville G, B\u00e9langer L, Ivers H The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601\u20138. Available from:. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21532953.","journal-title":"Sleep"},{"key":"7089_CR36","first-page":"153","volume-title":"Unified Parkinson\u2019s disease rating scale. In: Recent Developments in Parkinson\u2019s Disease","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL. Unified Parkinson\u2019s disease rating scale. Recent Developments in Parkinson\u2019s Disease. Volume 2. Florham Park, NJ: Macmillan Health Care Information; 1987. pp. 153\u201363."},{"issue":"15","key":"7089_CR37","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez\u2010Martin P, et al Movement Disorder Society\u2010sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS\u2010UPDRS): Scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129\u201370. Available from:. https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.22340.","journal-title":"Mov Disord"},{"key":"7089_CR38","unstructured":"Menza M, Dobkin RD, Marin H, Gara M, Bienfait K, Dicke A, et al. Treatment of Insomnia in Patients With Parkinson\u2019s Disease: A Multi-site, Placebo-controlled Study of Eszopiclone. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2006. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00324896."},{"key":"7089_CR39","unstructured":"Burdick D. A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2016. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02729714."},{"key":"7089_CR40","unstructured":"Ingelheim B. The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN\u2019s Disease Who Also Take L-Dopa. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2018. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03521635."},{"key":"7089_CR41","unstructured":"GlaxoSmithKline. A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson\u2019s Disease Who Are Not Optimally Controlled on L-Dopa. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2010. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01154166."},{"key":"7089_CR42","unstructured":"Adamas Pharmaceuticals I. Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2011. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01397422."},{"key":"7089_CR43","unstructured":"UCB Pharma. Placebo-Controlled Study in Patients With Parkinson\u2019s Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2011. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01300819."},{"key":"7089_CR44","unstructured":"UCB Pharma. Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine (RECOVER). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2015. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00474058."},{"key":"7089_CR45","unstructured":"UCB Pharma. Trial to Assess Parkinson\u2019s Disease Symptom Control to Four Doses of Rotigotine in a Transdermal Patch. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2007. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00522379."},{"key":"7089_CR46","unstructured":"Bial - Portela C S.A. Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson\u2019s Disease Patients With Wearing-Off Phenomenon Treated With Levodopa Plus a Dopa Decarboxylase Inhibitor (BIPARK-II). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2015. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01227655."},{"key":"7089_CR47","unstructured":"Otsuka Pharmaceutical Co. L. A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson\u2019s Disease Patients With Concomitant Treatment of L-dopa. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2009. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01628926."},{"key":"7089_CR48","unstructured":"AbbVie. A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson\u2019s Disease (PD). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2015. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02549092."},{"key":"7089_CR49","unstructured":"AbbVie (prior sponsor A. An Open-Label, Two Part, Multicenter Study to Assess the Safety and Efficacy of Levodopa-Carbidopa Intestinal Gel (LCIG) for the Treatment of Non-Motor Symptoms in Subjects With Advanced Parkinson\u2019s Disease. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2013. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01736176."},{"key":"7089_CR50","unstructured":"UCB BIOSCIENCES GmbH. A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson\u2019s Disease. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2014. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01723904."},{"key":"7089_CR51","unstructured":"Impax Laboratories L. Open-Label Extension Study of the Safety and Clinical Utility of IPX203 in Parkinson\u2019s Disease Participants With Motor Fluctuations. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03877510."},{"key":"7089_CR52","unstructured":"AbbVie. Study Comparing Continuous Subcutaneous Infusion of ABBV-951 to Oral Carbidopa\/Levodopa in Advanced Parkinson\u2019s Disease. 2020. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04380142."},{"key":"7089_CR53","unstructured":"AbbVie. A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson\u2019s Disease (PD). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2019. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03781167."},{"key":"7089_CR54","unstructured":"AbbVie. Open-Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Subjects With Advanced Parkinson\u2019s Disease and Severe Motor Fluctuations. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2009. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00660673."},{"key":"7089_CR55","unstructured":"Boehringer Ingelheim. Efficacy, Safety and Tolerability of Pramipexole Extended Release Versus Pramipexole Immediate Release Versus Placebo in Patients With Early Parkinson\u2019s Disease. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2007. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00479401."},{"key":"7089_CR56","unstructured":"Eli Lilly and Company. An Open-Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson\u2019s Disease. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2007. Available from: https:\/\/clinicaltrials.gov\/study\/NCT00437125."},{"key":"7089_CR57","unstructured":"Bial - Portela C S.A. Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson\u2019s Disease Patients With \u201cWearing-off\u201d Phenomenon. ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2011. Available from: https:\/\/clinicaltrials.gov\/study\/NCT01568073."},{"key":"7089_CR58","unstructured":"Schwarzschild MA. A Randomized, Double-Blind, Placebo-Controlled Trial of Urate-Elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson\u2019s Disease (SURE-PD3). ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US); 2016. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02642393."},{"key":"7089_CR59","doi-asserted-by":"crossref","unstructured":"Calandra-Buonaura G, Guaraldi P, Doria A, Zanigni S, Nassetti S, Favoni V, et al. Rotigotine Objectively Improves Sleep in Parkinson\u2019s Disease: An Open-Label Pilot Study with Actigraphic Recording. Parkinsons Dis. 2016;2016:1\u20135. Available from: http:\/\/www.hindawi.com\/journals\/pd\/2016\/3724148\/.","DOI":"10.1155\/2016\/3724148"},{"key":"7089_CR60","doi-asserted-by":"publisher","first-page":"1591537","DOI":"10.3389\/fneur.2025.1591537","volume":"16","author":"S Grigoriou","year":"2025","unstructured":"Grigoriou S, Janz C, Horne M, Bergquist F, Dizdar N, Odin P. Effects of rotigotine on sleep in Parkinson\u2019s disease patients: a Parkinson\u2019s KinetiGraph study. Front Neurol. 2025;16:1591537. Available from. https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1591537\/full.","journal-title":"Front Neurol"},{"issue":"1","key":"7089_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/jamaneurol.2017.3171","volume":"75","author":"F B\u00fcchele","year":"2018","unstructured":"B\u00fcchele F, Hackius M, Schreglmann SR, Omlor W, Werth E, Maric A, et al. Sodium Oxybate for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson Disease. JAMA Neurol. 2018;75(1):114. Available from: http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2017.3171.","journal-title":"JAMA Neurol"},{"key":"7089_CR62","doi-asserted-by":"crossref","unstructured":"Kataoka H, Takatani T, Sugie K. Two\u2010Channel Portable Biopotential Recording System Can Detect REM Sleep Behavioral Disorder: Validation Study with a Comparison of Polysomnography. Mirabella G, editor. Parkinsons Dis. 2022;2022(1). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2022\/1888682.","DOI":"10.1155\/2022\/1888682"},{"issue":"10","key":"7089_CR63","doi-asserted-by":"publisher","first-page":"3509","DOI":"10.1007\/s10072-023-06885-8","volume":"44","author":"G Bellelli","year":"2023","unstructured":"Bellelli G, Zucchelli A, Benussi A, Pinardi E, Caratozzolo S, Ornago AM, et al Assessing frailty at the centers for dementia and cognitive decline in Italy: potential implications for improving care of older people living with dementia. Neurol Sci. 2023;44(10):3509\u201314. Available from:. https:\/\/link.springer.com\/10.1007\/s10072-023-06885-8.","journal-title":"Neurol Sci"},{"issue":"1","key":"7089_CR64","doi-asserted-by":"publisher","first-page":"10658","DOI":"10.1038\/s41598-021-90125-6","volume":"11","author":"F Nari","year":"2021","unstructured":"Nari F, Jang BN, Youn HM, Jeong W, Jang S, Park E. Frailty transitions and cognitive function among South Korean older adults. Sci Rep. 2021;11(1):10658. Available from. https:\/\/www.nature.com\/articles\/s41598-021-90125-6.","journal-title":"Sci Rep"},{"key":"7089_CR65","doi-asserted-by":"crossref","unstructured":"Kozak-Szkopek E, Wdowiak K, Imiela AM, Ou-Pokrzewi\u0144ska A, Strz\u0105ska-Kli\u015b Z, Andrzejczyk A, et al. Frailty and Cognitive Decline in Hospitalized Elderly Patients: Associations with Clinical and Laboratory Parameters. Med Sci Monit. 2025;31. Available from: https:\/\/www.medscimonit.com\/abstract\/index\/idArt\/947354","DOI":"10.12659\/MSM.947354"},{"key":"7089_CR66","doi-asserted-by":"crossref","unstructured":"Yang C, Hou X, Ma X, Wu D. Frailty among inpatients with Schizophrenia: Status, influencing factors, and their correlation with quality of life. Front Psychiatry. 2023;13. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1067260\/full.","DOI":"10.3389\/fpsyt.2022.1067260"},{"issue":"4","key":"7089_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004553","volume":"22","author":"H Wightman","year":"2025","unstructured":"Wightman H, Butterly E, Wei L, McChrystal R, Sattar N, Adler A, et al. Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: an individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events. PLoS Med. 2025;22(4):e1004553.","journal-title":"PLoS Med"},{"issue":"11","key":"7089_CR68","first-page":"1810","volume":"10","author":"H Liu","year":"2018","unstructured":"Liu H, Yang Y, Xu D, Xia H, Pan D, Wang S, et al. Investigation and Comparison of Nutritional Supplement Use, Knowledge, and Attitudes in Medical and Non-Medical Students in China. Nutr. 2018;10(11):1810. Available from: https:\/\/www.mdpi.com\/2072-6643\/10\/11\/1810\/htm. Cited 4 Jun 2025.","journal-title":"Nutr"},{"issue":"2","key":"7089_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000507214","volume":"49","author":"V Bonfiglio","year":"2020","unstructured":"Bonfiglio V, Umegaki H, Kuzuya M A Study on the Relationship between Cognitive Performance, Hearing Impairment, and Frailty in Older Adults. Dement Geriatr Cogn Disord. 2020;49(2):156\u201362. Available from:. https:\/\/karger.com\/article\/doi\/10.1159\/000507214.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"7089_CR70","doi-asserted-by":"publisher","first-page":"668","DOI":"10.3390\/metabo13050668","volume":"13","author":"J Milanowski","year":"2023","unstructured":"Milanowski J, Kozerawski K, Fal\u0119cka W, Dudek D, Lisewska B, Lisewski P, et al Changes in the Secretion of Melatonin and Selected Adipokines during the Progression of Parkinson\u2019s Disease\u2014Preliminary Studies. Metabolites. 2023;13(5):668. Available from:. https:\/\/www.mdpi.com\/2218-1989\/13\/5\/668.","journal-title":"Metabolites"},{"key":"7089_CR71","doi-asserted-by":"crossref","unstructured":"Muehlroth BE, Werkle\u2010Bergner M. Understanding the interplay of sleep and aging: Methodological challenges. Psychophysiology. 2020;57(3). Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/psyp.13523.","DOI":"10.1111\/psyp.13523"},{"key":"7089_CR72","doi-asserted-by":"crossref","unstructured":"Chou CA, Toedebusch CD, Redrick T, Freund D, McLeland JS, Morris JC, et al. Comparison of single-channel EEG, actigraphy, and sleep diary in cognitively normal and mildly impaired older adults. SLEEP Adv. 2020;1(1). Available from: https:\/\/academic.oup.com\/sleepadvances\/article\/doi\/10.1093\/sleepadvances\/zpaa006\/5937495.","DOI":"10.1093\/sleepadvances\/zpaa006"},{"issue":"2","key":"7089_CR73","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41380-023-02335-1","volume":"29","author":"IF Orlando","year":"2024","unstructured":"Orlando IF, O\u2019Callaghan C, Lam A, McKinnon AC, Tan JBC, Michaelian JC, et al Sleep spindle architecture associated with distinct clinical phenotypes in older adults at risk for dementia. Mol Psychiatry. 2024;29(2):402\u201311. Available from:. https:\/\/www.nature.com\/articles\/s41380-023-02335-1.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"7089_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/clockssleep6010010","volume":"6","author":"C della Monica","year":"2024","unstructured":"della Monica C, Ravindran KKG, Atzori G, Lambert DJ, Rodriguez T, Mahvash-Mohammadi S, et al A Protocol for Evaluating Digital Technology for Monitoring Sleep and Circadian Rhythms in Older People and People Living with Dementia in the Community. Clocks Sleep. 2024;6(1):129\u201355. Available from:. https:\/\/www.mdpi.com\/2624-5175\/6\/1\/10.","journal-title":"Clocks Sleep"},{"issue":"11","key":"7089_CR75","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1097\/WNR.0000000000001689","volume":"32","author":"L Wang","year":"2021","unstructured":"Wang L, Peng D Altered intrinsic brain activity in mild Alzheimer\u2019s disease patients with sleep disturbances. NeuroReport. 2021;32(11):942\u20138. Available from:. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34132706.","journal-title":"NeuroReport"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07089-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07089-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:20:50Z","timestamp":1781634050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07089-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7089"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07089-3","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cNot applicable\u201d. This study is a descriptive registry-based review of publicly available registry records and published literature; no new human participants were recruited, and no identifiable data were collected. \u201cNot applicable\u201d. No human participants were enrolled by the authors in the conduct of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"401"}}